The advent of targeted therapeutics and implications for pathologists

Medical School Without Walls: 50 Years of Regional Campuses at Indiana University School of Medicine.

Academic medicine : journal of the Association of American Medical Colleges·2022

HoxA9 binds and represses the Cebpa +8 kb enhancer.

PloS one·2019

HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.

Cancer cell·2018

A new target for differentiation therapy in AML.

Cell research·2016

Deregulation of the HOXA9/MEIS1 axis in acute leukemia.

Current opinion in hematology·2016

PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity.

Molecular cell·2016

Risk factors for lymph node metastasis in a contemporary radical prostatectomy cohort.

American journal of clinical pathology·2026

Evaluation of a virulence gene repertoire as a means to investigate the role in the causal pathway to death of Escherichia coli isolated from postmortem specimens, northern Tanzania.

American journal of clinical pathology·2026

Optimizing diagnostic utility for diagnosis and management of Helicobacter pylori infections through combined microbiology and pathology approaches: a 7-year study.

American journal of clinical pathology·2026

Single-cohort next-generation sequencing analysis of 713 anaplastic thyroid carcinomas: unreported gene alterations and actionable targets.

American journal of clinical pathology·2026

Measurement of hemolysis in packed red blood cell segments and units using H index.

American journal of clinical pathology·2026

Pathology goes viral: a qualitative review of #pathology content on TikTok.

American journal of clinical pathology·2026

Occurrence of Infusion Associated Reactions and Antidrug Antibodies in Enzyme Replacement Therapy for Fabry Disease and the Effect of Preventive Measures.

Journal of inherited metabolic disease·2026

NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib.

Blood·2026

Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease.

Journal of the American Heart Association·2026

Inhibiting PIK3C3/VPS34 enhances anti-GD2 immunotherapy in neuroblastoma.

Autophagy·2026

Toward Personalized Theranostics: A Modular PET Platform for Antibody-Based Imaging and Therapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery.

ACS medicinal chemistry letters·2026

Related Experiment Videos

The advent of targeted therapeutics and implications for pathologists

Related Concept Videos

Medical School Without Walls: 50 Years of Regional Campuses at Indiana University School of Medicine.

HoxA9 binds and represses the Cebpa +8 kb enhancer.

HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.

A new target for differentiation therapy in AML.

Deregulation of the HOXA9/MEIS1 axis in acute leukemia.

PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity.

Risk factors for lymph node metastasis in a contemporary radical prostatectomy cohort.

Evaluation of a virulence gene repertoire as a means to investigate the role in the causal pathway to death of Escherichia coli isolated from postmortem specimens, northern Tanzania.

Optimizing diagnostic utility for diagnosis and management of Helicobacter pylori infections through combined microbiology and pathology approaches: a 7-year study.

Single-cohort next-generation sequencing analysis of 713 anaplastic thyroid carcinomas: unreported gene alterations and actionable targets.

Measurement of hemolysis in packed red blood cell segments and units using H index.

Pathology goes viral: a qualitative review of #pathology content on TikTok.

Occurrence of Infusion Associated Reactions and Antidrug Antibodies in Enzyme Replacement Therapy for Fabry Disease and the Effect of Preventive Measures.

NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib.

Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease.

Inhibiting PIK3C3/VPS34 enhances anti-GD2 immunotherapy in neuroblastoma.

Toward Personalized Theranostics: A Modular PET Platform for Antibody-Based Imaging and Therapy.

Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery.

Related Experiment Videos

The advent of targeted therapeutics and implications for pathologists

Related Concept Videos

Related Articles